Marinus Pharmaceuticals, Inc. provided revenue guidance for the fiscal year 2022. For the period, the company expects BARDA revenues in the range of $7 to $10 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +1.50% | -8.78% | -87.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.58% | 73.06M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- MRNS Stock
- News Marinus Pharmaceuticals, Inc.
- Marinus Pharmaceuticals, Inc. Provides Revenue Guidance for the Fiscal Year 2022